Description
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P
Technology
Stats
- 25,481 US PATENTS IN FORCE
- 47,418 US APPLICATIONS PENDING
- 15,724 Total Patent Owners
- 218,844 TOTAL INVENTORS
Subclasses
| Subclass | Title |
|---|---|
| 1/00 | Drugs for disorders of the alimentary tract or the digestive system |
| 1/02 | Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis |
| 1/04 | Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants |
| 1/06 | Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia |
| 1/08 | Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics |
| 1/10 | Drugs for disorders of the alimentary tract or the digestive system Laxatives |
| 1/12 | Drugs for disorders of the alimentary tract or the digestive system Antidiarrhoeals |
| 1/14 | Drugs for disorders of the alimentary tract or the digestive system Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents |
| 1/16 | Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics |
| 1/18 | Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes |
| 3/00 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) |
| 3/02 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Nutrients, e.g. vitamins, minerals |
| 3/04 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Anorexiants; Antiobesity agents |
| 3/06 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics |
| 3/08 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) |
| 3/10 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) for hyperglycaemia, e.g. antidiabetics |
| 3/12 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis |
| 3/14 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/1; bone metastasis A61P 35/04) |
| 5/00 | Drugs for disorders of the endocrine system |
| 5/02 | Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin |
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| RE49948 | Aryl ethers and uses thereof | Feb 03, 22 | Apr 30, 24 | Peloton Therapeutics, Inc. |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0172,756 | ORGANOANTIMONY(V) CYANOXIMATE COMPOUNDS AND METHODS OF PRODUCTION AND USE THEREOF | Feb 23, 22 | May 30, 24 | Not available |
| 2024/0173,240 | COSMETIC COMPOSITION COMPRISING CERAMIDES AND SPHINGOLIPID | Apr 04, 23 | May 30, 24 | Croda Korea Ltd |
| 2024/0173,257 | Liposome formulations | Jul 06, 21 | May 30, 24 | Thermosome GmbH |
| 2024/0173,258 | LIPOSOME COMPOSITIONS AND METHODS OF USE THEREOF | Nov 01, 23 | May 30, 24 | Not available |
| 2024/0173,262 | MUCOADHESIVE PHARMACEUTICAL DOSAGE FORM FOR UNIDIRECTIONAL RELEASE OF PEPTIDE THERAPEUTIC PARTICLES | Nov 17, 23 | May 30, 24 | The University of British Columbia |
| 2024/0173,264 | NEW PHARMACEUTICAL COMPOSITIONS | Dec 21, 23 | May 30, 24 | Not available |
| 2024/0173,267 | COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | Jan 06, 22 | May 30, 24 | ONCORUS, INC. |
| 2024/0173,273 | USE OF PANTETHINE FOR THE TREATMENT OF SARS COV-2 INFECTIONS | Mar 23, 22 | May 30, 24 | Not available |
| 2024/0173,274 | MIRDAMETINIB TREATMENT | Nov 22, 23 | May 30, 24 | Not available |
| 2024/0173,275 | POTENTIATION OF HELMINTH TREATMENT | Feb 02, 24 | May 30, 24 | Not available |
| 2024/0173,276 | METHODS AND COMPOSITIONS FOR INHIBITING FORMATION OF THE HIV LATENT RESERVOIR | Mar 22, 22 | May 30, 24 | Not available |
| 2024/0173,277 | ANTI-MYCOBACTERIAL DRUGS | Nov 10, 23 | May 30, 24 | The Florida International University Board of Trustees |
| 2024/0173,279 | Method of Treatment for Autophagy Diseases by Administration of Dexibuprofen and Use of Dexibuprofen for Preparation of a Medicament for Same | Oct 24, 23 | May 30, 24 | JEM THERAPEUTICS PBC |
| 2024/0173,280 | METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME | Jan 31, 24 | May 30, 24 | Not available |
| 2024/0173,288 | COMPOUNDS, COMPOSITIONS, METHODS OF USING, AND METHODS FOR PREPARING COMPOUNDS | Oct 26, 23 | May 30, 24 | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.; THE INSTITUTE FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE (INSTEM); |
| 2024/0173,289 | USE OF OXYMETHYL-MODIFIED DERIVATIVE OF QUERCETIN IN PREPARATION OF DRUG FOR INHIBITING TUMOR CELL PROLIFERATION | Apr 20, 22 | May 30, 24 | Hangzhou Zhejiang University Sensing Instruments Co., Ltd. |
| 2024/0173,291 | SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS | Dec 14, 23 | May 30, 24 | Not available |
| 2024/0173,292 | COMPOUNDS THAT SYNERGIZE WITH COPPER TO KILL STREPTOCOCCUS PNEUMONIAE | Dec 15, 23 | May 30, 24 | Not available |
| 2024/0173,293 | Treatment of Breast Cancer with Amcenestrant and Palbociclib | Mar 02, 22 | May 30, 24 | Sanofi; Pfizer Inc.; |
| 2024/0173,295 | A STABLE, EMULSION-FORMING LIQUID COMPOSITION COMPRISING AMINO ACIDS | Mar 25, 22 | May 30, 24 | Not available |
Top Owners in This Class
| Upgrade to the Professional Level to view Top Owners for this Class.Learn More |
|---|
Applications Filed in This Class - By Year
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 31 Months (last 2 years Issuances)
- 31 Months (last 5 years Issuances)